Literature DB >> 2732726

Class II HLA antigens in multiple sclerosis.

D H Miller1, R W Hornabrook, J Dagger, R Fong.   

Abstract

HLA typing in Wellington revealed a stronger association of multiple sclerosis with DR2 than with DQw1. The association with DQw1 appeared to be due to linkage disequilibrium of this antigen with DR2. These results, when considered in conjunction with other studies, are most easily explained by the hypothesis that susceptibility to multiple sclerosis is influenced by multiple risk factors, with DR2 being an important risk factor in Caucasoid populations.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2732726      PMCID： PMC1032162          DOI： 10.1136/jnnp.52.5.575

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  21 in total

1.  A single mutation hypothesis for multiple sclerosis based on the HL-A system.

Authors:  P I Terasaki; M R Mickey
Journal:  Neurology       Date:  1976-06       Impact factor: 9.910

Review 2.  The significance of the association between HLA and multiple sclerosis.

Authors:  J R Batchelor; A Compston; W I McDonald
Journal:  Br Med Bull       Date:  1978-09       Impact factor: 4.291

3.  Histocompatibility determinants in multiple sclerosis, with special reference to clinical course.

Authors:  C Jersild; T Fog; G S Hansen; M Thomsen; A Svejgaard; B Dupont
Journal:  Lancet       Date:  1973-12-01       Impact factor: 79.321

4.  HL-A antigens and multiple sclerosis.

Authors:  C Jersild; A Svejgaard; T Fog
Journal:  Lancet       Date:  1972-06-03       Impact factor: 79.321

5.  HLA and multiple sclerosis in south east Wales.

Authors:  R J Swingler; P F Kirk; C Darke; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

Review 6.  Diagnosis and classification of multiple sclerosis.

Authors:  W I McDonald; A M Halliday
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

7.  The association of HLA antigens A3, B7, and DW2 with 330 multiple sclerosis patients in the United States.

Authors:  G Opelz; P Terasaki; L Myers; G Ellison; G Ebers; J Zabriskie; H Weiner; H Kempe; W Sibley
Journal:  Tissue Antigens       Date:  1977-01

8.  Immunoglobulin G heavy chain (Gm) allotypes in multiple sclerosis.

Authors:  J P Pandey; J M Goust; J P Salier; H H Fudenberg
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

9.  Evidence for lower susceptibility to multiple sclerosis in Japanese-Americans.

Authors:  R Detels; B R Visscher; R M Malmgren; A H Coulson; M V Lucia; J P Dudley
Journal:  Am J Epidemiol       Date:  1977-04       Impact factor: 4.897

10.  Sequelae of concussion caused by minor head injuries.

Authors:  W H Rutherford
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321
View more
  2 in total

1.  Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental?

Authors:  D H Miller; S R Hammond; J G McLeod; G Purdie; D C Skegg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

2.  CD24 is a genetic modifier for risk and progression of multiple sclerosis.

Authors:  Qunmin Zhou; Kottil Rammohan; Shili Lin; Nikki Robinson; Ou Li; Xingluo Liu; Xue-feng Bai; Lijie Yin; Bruce Scarberry; Peishuang Du; Ming You; Kunliang Guan; Pan Zheng; Yang Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.